Reconova closes Series C+ at CNY2.06B post-money
Reconova completed its Series C+ financing at an issuer-disclosed CNY2.06B post-money valuation. The filing lists CNY60000000 of primary consideration among the disclosed retained investors.
Evidence notes
- Issuer prospectus states pre-money valuation of CNY2000000000 and post-money valuation of CNY2060000000.
- Primary consideration treatment: CNY60M primary subscription; separately listed February 2021 share transfers are excluded.
- Investors: Shanghai Shi Chuan Intelligent Technology Partnership